Thymic malignancies: from clinical management to targeted therapies
Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
[引用][C] Thymic Malignancies: From Clinical Management to Targeted Therapies
RJ KELLY, I PETRINI, A RAJAN… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Thymic Malignancies: From Clinical Management to Targeted Therapies CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
[HTML][HTML] Thymic Malignancies: From Clinical Management to Targeted Therapies
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
Thymic Malignancies: From Clinical Management to Targeted Therapies
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of Clinical …, 2011 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> A key challenge in the treatment of
thymoma and thymic carcinoma (TC) is in improving our understanding of the molecular …
thymoma and thymic carcinoma (TC) is in improving our understanding of the molecular …
Thymic malignancies: from clinical management to targeted therapies.
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of Clinical …, 2011 - europepmc.org
Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
Thymic malignancies: from clinical management to targeted therapies
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
Thymic malignancies: From clinical management to targeted therapies
RJ Kelly, I Petrini, A Rajan, Y Wang… - JOURNAL OF CLINICAL …, 2011 - arpi.unipi.it
PURPOSE: A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
Thymic malignancies: From clinical management to targeted therapies
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of Clinical …, 2011 - pure.johnshopkins.edu
Purpose: A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …
Thymic malignancies: from clinical management to targeted therapies.
RJ Kelly, I Petrini, A Rajan, Y Wang… - Journal of Clinical …, 2011 - europepmc.org
Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …
improving our understanding of the molecular biology of these relatively rare tumors. In …